Shilajit

Shilajit operates through multiple pharmacologic mechanisms reflecting its complex mineral-organic matrix composition. The major active fractions — fulvic acid, dibenzo-α-pyrones (DBPs), DBP-chromoproteins, small peptides, and chelated trace minerals — each contribute distinct mechanisms that converge on the compound's characteristic effects on energy, reproductive health, cognition, and aging.

1. Mitochondrial function and CoQ10 recycling (DBP mechanism — possibly shilajit's most distinctive effect). Shilajit's dibenzo-α-pyrones (DBPs, particularly 3,8-dihydroxy-dibenzo-α-pyrone) have been shown to participate in mitochondrial electron transport and facilitate the reduction of oxidized ubiquinone (ubiquinone / CoQ10-Q10 oxidized form) back to reduced ubiquinol (CoQ10-H2). Since CoQ10 must cycle between oxidized and reduced forms during its role in Complex III electron transport, any factor that facilitates this cycling can improve overall mitochondrial efficiency. DBPs have been shown to: (a) spare endogenous CoQ10 (Bhattacharyya et al., 2009) — maintaining higher ubiquinol/ubiquinone ratios under stress; (b) improve cellular ATP production in muscle, brain, and other energy-demanding tissues; (c) reduce lactate accumulation during exercise; (d) preserve mitochondrial membrane potential under oxidative stress; (e) reduce reactive oxygen species (ROS) production through electron-cycling normalization. This mitochondrial mechanism underlies many of shilajit's clinical effects on fatigue, exercise performance, and neuroprotection.

2. Testosterone and hypothalamic-pituitary-gonadal (HPG) axis modulation. Clinical trials (Pandit et al. 2016; Biswas et al. 2010) have shown significant increases in total and free testosterone with PrimaVie shilajit supplementation in both oligospermic and healthy-testosterone men. Proposed mechanisms include: (a) Leydig cell support — antioxidant protection of testicular steroidogenic cells; (b) enhanced LH sensitivity and possibly LH elevation; (c) preservation of testosterone precursors (DHEA, androstenedione); (d) reduced cortisol interference with testosterone production; (e) improved blood flow to reproductive tissues; (f) direct effects on spermatogenesis — increased sperm count, motility, and morphology. This HPG-axis effect is one of shilajit's most strong and reproducible clinical findings.

3. Fulvic acid pharmacology. Fulvic acid is a structurally complex mixture of polyhydroxylic organic acids with unique properties: (a) mineral chelation and bioavailability enhancement — fulvic acid forms stable but bioavailable complexes with iron, zinc, magnesium, and many other minerals, improving absorption; (b) membrane transport modulation — fulvic acid can shuttle minerals and small molecules across cell membranes; (c) direct antioxidant effects — multiple polyhydroxy groups provide substantial radical scavenging capacity; (d) electron shuttling supporting redox reactions; (e) anti-amyloid effects — of particular interest in Alzheimer's research, fulvic acid has been shown to inhibit tau self-aggregation and amyloid fibril formation; (f) anti-inflammatory effects modulating NF-κB and cytokine production; (g) immunomodulation through various mechanisms. The fulvic acid contribution is probably why shilajit is effective for iron-deficiency anemia and certain cognitive applications.

4. Neuroprotective mechanisms (Alzheimer's / cognitive disease relevance). Shilajit's proposed effects on cognitive decline operate through multiple pathways: (a) tau and amyloid modulation — fulvic acid inhibits tau protein self-aggregation (Cornejo et al. 2011) and amyloid-β fibril formation; (b) DBP effects on mitochondrial function in neurons supporting energetic function; (c) anti-oxidant protection of neural tissue; (d) anti-inflammatory effects reducing neuroinflammation; (e) cholinergic support through mechanisms still being characterized; (f) iron regulation — important since both iron overload and iron deficiency contribute to neurological dysfunction. The Alzheimer's disease research program for shilajit (particularly Spanish/Chilean researchers) represents a substantial ongoing scientific investigation.

5. Iron metabolism modulation (anemia and iron regulation). Shilajit has unique effects on iron homeostasis: (a) enhanced iron absorption through fulvic acid chelation — highly bioavailable iron forms are delivered without the GI upset of ferrous sulfate; (b) reduced iron-catalyzed oxidative damage despite facilitating absorption (fulvic acid binding keeps iron in reduced pro-oxidant-low state); (c) hepcidin modulation affecting systemic iron handling; (d) improved hemoglobin synthesis; (e) support for iron-dependent enzymes (catalase, peroxidases, cytochromes). This makes shilajit an interesting option for iron deficiency anemia — combining enhanced absorption with reduced oxidative burden compared to typical ferrous sulfate.

6. Exercise performance and muscle function. Mechanisms relevant to exercise performance include: (a) mitochondrial efficiency via DBP mechanisms already described; (b) reduced exercise-induced muscle damage — preserved muscle integrity in exercise studies; (c) enhanced collagen synthesis — Keller et al. 2017 showed elevated hydroxyproline marker with shilajit; (d) improved recovery markers — reduced CK and LDH after exercise; (e) testosterone support benefiting training adaptations; (f) reduced fatigue through multiple convergent mechanisms; (g) potentially enhanced ATP resynthesis between bouts. This supports athletic use including strength training, endurance activities, and exercise recovery.

7. Antioxidant and anti-inflammatory mechanisms. Shilajit's multi-compound antioxidant effects include: (a) direct radical scavenging by phenolic groups in fulvic acid; (b) metal chelation reducing Fenton-chemistry-generated ROS; (c) enhancement of endogenous antioxidants — superoxide dismutase, catalase, glutathione peroxidase; (d) mitochondrial ROS reduction via DBP mechanisms; (e) NF-κB inhibition reducing transcription of pro-inflammatory genes; (f) cytokine modulation — reducing TNF-α, IL-1β, IL-6 while potentially improving anti-inflammatory cytokines. This combined antioxidant-inflammatory effect contributes to most of shilajit's clinical benefits.

8. Immunomodulatory effects. Shilajit modulates immune function through: (a) macrophage function support — enhanced phagocytosis and appropriate cytokine production; (b) T-cell balance modulation — adaptogenic effect on adaptive immunity; (c) NK cell activity enhancement in some contexts; (d) anti-inflammatory effects moderating excessive inflammation; (e) antimicrobial activity — some direct effects against various pathogens. Unlike aggressive immunostimulants, shilajit appears to have relatively balanced immune-modulating effects suitable for long-term use.

9. Anti-ulcer and gastroprotective effects. Traditional use of shilajit for GI complaints is supported by modern mechanisms: (a) mucus production enhancement in gastric mucosa; (b) prostaglandin synthesis support for mucosal defense; (c) anti-ulcer effects demonstrated in multiple animal models; (d) antimicrobial activity against H. pylori; (e) anti-inflammatory effects in gastric/intestinal tissue; (f) improved mucosal healing in ulcerated tissue.

10. Bone metabolism and fracture healing. Both classical Ayurvedic use and Soviet mumijo research emphasized bone/fracture applications, supported by mechanisms including: (a) mineral bioavailability enhancement via fulvic acid chelation (calcium, magnesium, boron, zinc); (b) osteoblast activity support; (c) collagen synthesis for bone matrix; (d) anti-inflammatory effects on fracture sites; (e) enhanced wound/tissue repair generally. Traditional applications for bone fracture healing have modern mechanistic plausibility.

Pharmacokinetics (what we know): Shilajit's fulvic acid component is orally bioavailable but not extensively characterized — different molecular weight fractions have different absorption profiles. DBPs are absorbed orally with plasma levels detectable within hours. Chelated minerals have enhanced bioavailability compared to typical mineral salts. Elimination pathways include both urinary (for smaller molecules) and biliary. Half-life data varies by compound — shilajit as a whole has poorly characterized pharmacokinetics, reflecting its mineral-organic matrix nature.

Shilajit (Sanskrit: shilajatu, αñ╢αñ┐αñ▓αñ╛αñ£αññαÑü, literally "rock-conqueror" or "rock-invincible"; Hindi/Urdu: shilajit; Persian and Central Asian: mumijo, moomiyo, mumiyo; Pashto/Afghan: salajeet; Latin pharmacopeial: Asphaltum Punjabinum) is a blackish-brown, sticky, resin-like mineral-organic exudate that oozes from cracks in rock formations in high-altitude mountain ranges, most famously the Himalayas and Karakoram but also the Altai, Tien Shan, Caucasus, and Hindu Kush ranges. Unlike almost every other substance in traditional herbal medicine, shilajit is not a plant — it's a complex mineral-organic matrix formed over centuries to millennia by the slow decomposition of specific plant materials (predominantly Euphorbia royleana, Trifolium repens, Barleria prionitis, and various mosses and lichens) subjected to heat, pressure, geological compression, and microbial action within rock formations. The resulting exudate, when harvested by scraping it from rock crevices at elevations of 3,000-5,000 meters, has a characteristic tarry, bitumen-like texture and a complex bitter-salty taste.

Shilajit holds special status in Ayurveda (the classical Indian medical system) as a rasayana — a rejuvenative substance — and specifically as a "maharasa" (great rasa, or supreme substance). The Charaka Samhita (~400 BCE) refers to shilajit extensively, stating that "there is no curable disease which cannot be cured by shilajit, taken with the appropriate carrier substance (anupana)." The Sushruta Samhita and later texts like Rasa Shastra treatises (medieval period) provide detailed processing protocols (shodhana — purification). Classical Ayurvedic theory classifies shilajit by the mountain source it derives from — mountains containing gold (svarna shilajit), silver (rajata), copper (tamra), or iron (lauha) — each described as having somewhat different therapeutic profiles. The most prized is gold-mountain shilajit, described as golden-brown rather than pure black. Modern commercial shilajit typically doesn't specify this classical classification.

Central Asian and Russian traditions know shilajit as mumijo (Russian: ╨╝╤â╨╝╨╕╤æ, also transliterated as moomiyo, mumiyo, mummy), with extensive Soviet-era pharmacological and clinical research in Russia, Kazakhstan, Uzbekistan, Tajikistan, and Kyrgyzstan. Soviet research from the 1960s-1980s investigated mumijo for wound healing, bone fracture repair, rheumatism, gastrointestinal ulcers, and athletic performance — yielding substantial literature that is separately pharmacologically instructive but often methodologically limited by contemporary standards. The Central Asian mumijo tradition is distinct from but parallel to the South Asian Ayurvedic shilajit tradition, and both refer to essentially the same substance with regional variations in sourcing and processing.

The primary bioactive compounds in shilajit span several chemical classes. Fulvic acid (FvA) — a family of low-molecular-weight humic substances — is typically the most-abundant marker compound, comprising 15-50%+ of quality purified shilajit. Fulvic acid is a complex mixture of aromatic polyhydroxylic organic acids formed during organic matter decomposition, with established roles in mineral chelation, cell membrane transport, and electron shuttling. Humic acid — a higher molecular weight cousin of fulvic acid — is also present but typically filtered out in quality purified preparations due to lower bioavailability and higher potential for contamination. Dibenzo-α-pyrones (DBPs, also called urolithins-related compounds or chromenes) are a class of heterocyclic compounds unique to shilajit, with dibenzo-α-pyrone itself (3,8-dihydroxy-DBP, or 3,8-dihydroxy dibenzo-α-pyrone) and related compounds shown to have specific antioxidant, mitochondrial, and ubiquinone-sparing effects. DBP-chromoproteins are shilajit-specific chromoprotein complexes containing DBPs bound to protein structures. Low-molecular-weight peptides (typically <5 kDa) contribute to some biological effects. Trace minerals include iron, copper, zinc, manganese, magnesium, potassium, calcium, and many others in chelated forms bound to fulvic acid. Selenium is present and contributes to antioxidant effects. Quality standardized shilajit preparations typically report fulvic acid content (35-50%+ common in premium products) and sometimes DBP content.

The proposed clinical applications of shilajit span: (1) energy, fatigue, and chronic fatigue syndrome — perhaps the primary traditional and modern use, with growing evidence for mitochondrial function improvement; (2) male reproductive health / testosterone — one of the better-evidenced modern applications with specific RCTs showing testosterone elevation and improvements in spermatogenesis; (3) exercise performance and recovery — evidence for muscle strength, recovery markers, and athletic performance; (4) cognitive function and Alzheimer's disease — preliminary evidence for cognitive support particularly through DBP effects on amyloid and tau; (5) iron absorption and anemia — traditional use with modern rationale based on fulvic acid chelation; (6) bone health and fracture healing — classical "destroyer of weakness" including bone applications; (7) wound healing — Soviet mumijo tradition and modern research; (8) gastric/GI health — including traditional and modern evidence for peptic ulcer support; (9) adaptogenic effects — the general rejuvenation and stress-resilience tradition; and (10) heavy metal detoxification — proposed fulvic acid effects, though this is controversial given contamination risk.

Human clinical evidence for shilajit has grown substantially over the past 2 decades, with Indian pharmaceutical companies (particularly Natreon Inc., makers of PrimaVie shilajit) funding most Western-style RCTs. Key trials: Biswas et al. 2010 (Andrologia) — RCT of PrimaVie purified shilajit (250mg twice daily) in 60 oligospermic (low sperm count) men for 90 days showed significant improvements in sperm count, motility, and quality. Pandit et al. 2016 (Andrologia) — RCT of PrimaVie shilajit (250mg twice daily) in 75 men aged 45-55 with healthy testosterone for 90 days showed significant total and free testosterone elevation. Keller et al. 2017 (Journal of the International Society of Sports Nutrition) — RCT examining shilajit effects on hydroxyproline (collagen synthesis marker) and exercise-related outcomes. Das et al. 2016 (Scientifica) — demonstrated shilajit effects on fatigue and quality of life in chronic fatigue syndrome. Cornelli et al. 2011 — examined shilajit in cognitive function outcomes. Carrasco-Gallardo et al. 2012 (International Journal of Alzheimer's Disease) — reviewed shilajit's mechanistic potential in Alzheimer's disease with particular focus on DBP effects.

Where does shilajit fit in the therapeutic landscape? It has a distinctive profile: (1) a mineral-organic matrix rather than a conventional herb, offering very different pharmacology than plant-based adaptogens; (2) a specific male reproductive tonic role with better testosterone data than most natural products (Tongkat Ali is comparable); (3) mitochondrial and CoQ10-sparing effects through DBPs — mechanistically distinct from other adaptogens; (4) fulvic acid pharmacology not shared with other supplements — effects on mineral absorption, electron transport, and possibly neuroprotection; (5) classical framing as "destroyer of weakness" covering a wide range of aging-related decline; and (6) significant quality-control sensitivity — a substance requiring serious vetting given contamination history. It pairs meaningfully with Ashwagandha (the other pillar of Ayurvedic male tonics — different mechanisms, complementary effects), Tongkat Ali (shared testosterone focus with different mechanisms), Fadogia agrestis (testosterone emphasis), Tribulus terrestris (Ayurvedic companion), CoQ10 (complementary mitochondrial support — DBPs help recycle CoQ10), NAD+ precursors (mitochondrial/longevity focus), Creatine (exercise performance), Tulsi (classical Ayurvedic pairing), and Bacopa monnieri (Ayurvedic cognitive support pairing).

Safety profile is excellent for properly purified shilajit but dismal for unpurified/contaminated preparations — a critical distinction. Raw shilajit from rock faces contains significant mycotoxins, free radicals, polymeric quinones, and potentially toxic heavy metals (especially lead, arsenic, mercury) requiring proper shodhana (Ayurvedic purification) or modern purification processes. Quality purified shilajit with verified low heavy metal content has excellent safety. Unpurified or poorly purified shilajit can be actively dangerous. This makes supplier selection and third-party testing absolutely essential — more so than perhaps any other adaptogen.

IUPAC Name

Not yet available

CAS Number

Not yet available

Molecular Formula

Not yet available

Molecular Mass

Not yet available

Unlock Dosing Protocols

Free account gets you:

• View beginner, intermediate & advanced protocols
• See weight-based dosing calculations
• Access cycle length & frequency data

2,800+ researchers already in

Unlock Research Data

Free account gets you:

• Browse PubMed study summaries
• See clinical trial phases & results
• Access mechanism of action details

2,800+ researchers already in

Get Shilajit Price Drop Alerts

Set a target price and we'll notify you when any vendor drops below it.

Related Compounds

Side-by-Side Comparisons

Data Completeness